Skip to content

Effect of probiotics on bladder function

Effect of probiotics on bladder function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113403
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-16
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weak bladder

Interventions

Probiotic group:Oral probiotic powder, once a day, 1 bag each time (each bag contains =109 CFU of active probiotics)
Placebo group:Oral placebo, 1 bag per day (maltodextrin)

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 40 years old to 80 years old. 2. Gender: Unrestricted. 3. No antibiotic treatment within the past month. 4. No anti-inflammatory treatment within the past month. 5. Clinical diagnosis of weak bladder. 6. Subjects are willing to maintain normal eating and exercise habits to avoid significant weight changes during the study period and are able to understand the nature of the study. 7. Able to sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Subjects with severe chronic diseases (including heart failure, renal failure, lung disease, rheumatism, stroke, chronic cancer, or blood diseases, etc.) 2. Subjects with severe cardiovascular and cerebrovascular diseases and related surgical history 3. Subjects requiring long-term antibacterial or antiviral treatment 4. Subjects who have undergone cholecystectomy, intestinal resection, or gastrectomy 5. Acute inflammation 6. End-stage renal failure 7. Abnormal heart rhythm (lower or higher than 60-100 bpm) 8. Subjects allergic to maltodextrin or other drugs 9. Malignant tumors 10. Subjects who participated in another study within one month before the start of the study 11. Subjects who received medications that may affect the urinary system or took prebiotic or probiotic dietary supplements 12. Subjects who have lost more than 10% of their weight in the past 6 months or are currently dieting Pregnant women 13. Subjects allergic to medications 14. Subjects deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Postvoid residual urine volume;Body mass index (BMI);Serum inflammatory factor levels;Serum metabolome ;3*24-hour urination frequency;3*24-hour dietary ;Fecal and urine microbiome ;

Countries

China

Contacts

Public ContactMa Xin

Affiliated Hospital of Jiangnan University

maxin@jiangnan.edu.cn+86 189 5158 1116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026